Clinical Trials

55 enrolled

Breast Neoplasms

NCT06274034 2025-12-16

MUSE-S Headband System for Improving Anxiety and Insomnia Among Breast Cancer Survivors

40 enrolled

Breast Neoplasms

NCT05142475 2025-12-11

A Study of GC101 TIL in Advanced Breast Cancer (10hospital)

50 enrolled

Phase EARLY_PHASE1 Withdrawn

Breast Neoplasms

NCT05957042 2025-12-10

Pilot Study to Evaluate if Contrast Enhanced Ultrasound (CEUS) Can Predict Treatment Response in Triple Negative Breast Cancer (TNBC) Patients Receiving Combined Chemotherapy and Immune Checkpoint Inhibitors (ICI).

Breast Neoplasms

NCT06008275 2025-11-10

Neratinib in Combination With Ruxolitinib in Patients With mTNBC

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT04821375 2025-10-29

Pilot Study of Bazedoxifene Plus Conjugated Estrogen on Imaging and Blood Biomarkers

16 enrolled

Phase EARLY_PHASE1 Terminated

Breast Neoplasms

NCT04712721 2025-10-10

Study of [68Ga]-FF58 in Patients With Selected Solid Tumors Expected to Overexpress αvβ3 and αvβ5 Integrins.

14 enrolled

BreastCNS

Brain Neoplasms, Breast Neoplasms, Glioblastoma

NCT05754749 2025-09-25

Comparison of CE-DBT and MRI in Patients With Known Breast Lesions

Breast Neoplasms

NCT03802604 2025-09-09

PROMETEO

28 enrolled

Phase EARLY_PHASE1 Active not recruiting

Breast Neoplasms

NCT04147494 2025-08-12

Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues

29 enrolled

BreastGastrointestinalGenitourinaryGynecologicThoracic

Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

NCT05859971 2025-07-29

ICG and SLN Mapping

10 enrolled 7 charts

Breast Neoplasms

NCT06411678 2025-06-17

Application of 68GA-labeled CD73 Targeting Probe PET/CT Imaging in the Diagnosis of Breast Cancer

50 enrolled

Phase EARLY_PHASE1 Enrolling by invitation

Breast Neoplasms

NCT07023848 2025-06-17

PET Image Exploration of 89Zr-labeled Antibody Fragments Targeting HER2 in Patients With Malignant Tumors

10 enrolled

BreastGastrointestinalGenitourinary

Breast Neoplasms, Carcinoma, Transitional Cell, Stomach Neoplasms

NCT07023861 2025-06-17

The Exploration of Novel Radionuclide-labeled HER2-targeting Antibodies in the Diagnosis of HER2-positive Malignancies

Phase EARLY_PHASE1 Enrolling by invitation

BreastGastrointestinalGenitourinary

Breast Neoplasms, Carcinoma, Transitional Cell, Stomach Neoplasms

NCT06145399 2025-05-18

A Study of 1 8F-FDHT PET/MRIScans in Women With Breast Cancer

Phase EARLY_PHASE1 Withdrawn

Breast Neoplasms

NCT03685175 2025-03-30

HPCardiotox

79 enrolled

Breast Neoplasms

NCT06637306 2025-03-26

Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast Cancer

15 enrolled

Phase EARLY_PHASE1 Not yet recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06756295 2025-03-12

FAST-CR

154 enrolled

BreastDermatologicGastrointestinalThoracic

Breast Neoplasms, Lung Neoplasms, Melanoma, Colorectal Neoplasms

NCT06760429 2025-01-06

Comparative Evaluation of Pectoral Nerve Block Type II Versus Rhomboid Intercostal and Subserratus Plane Block in Breast Cancer Mastectomy for Postoperative Analgesia: a Randomized, Controlled Trial

60 enrolled

Breast Neoplasms

NCT04674722 2024-12-09

HER2 Expression Detection and Radionuclide Therapy in Breast Cancer Using 99mTc/188Re Labeled Single Domain Antibody

43 enrolled

Phase EARLY_PHASE1 Terminated

Breast Neoplasms

NCT03514121 2024-11-22

FPA150-001

95 enrolled 36 charts

BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT03629717 2024-10-16

RANKL Inhibition and Breast Tissue Biomarkers

10 enrolled

Breast Neoplasms

NCT03911453 2024-10-03

Window of Opportunity Trial, PARP Inhibitor Rucaparib Affect on PD-L1 Expression in Triple Negative Breast Tumors

Breast Neoplasms

NCT04481230 2024-10-01

CARSPECT

6 enrolled

Breast Neoplasms, Osteoarthritis, Knee

NCT02913430 2024-09-23

Treatment of Metastatic Breast Cancer With Fulvestrant Plus Palbociclib or Tamoxifen Plus Palbociclib

7 enrolled 13 charts

Phase EARLY_PHASE1 Withdrawn

Breast Neoplasms

NCT05672342 2024-08-09

Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors

BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms

NCT02415387 2024-07-24

IMPACT

172 enrolled 14 charts